(888) 440-0954


MedGenome’s OncoPept™ Named ‘Best Overall Genomics Solution’ in 2018 MedTech Breakthrough Awards

MedGenome’s OncoPept™ platform of advanced genomics-based solutions designed to accelerate cancer immune-oncology research, was named the winner of the 2018 MedTech Breakthrough Awards for ‘Best Overall Genomics Solution.’

New biomarker discovery could mean a daily pill can replace daily insulin shots for some children

A breakthrough study has identified a new biomarker that may be able to significantly improve the accuracy of diabetes diagnoses in children. Children thought to have Type 1 diabetes might actually have a variation caused by a single gene defect, and those children might find an affordable daily pill is the best treatment vs. daily insulin injections.

MedGenome, Kailash Cancer Hospital discovers genetic mutation of rare colorectal disorder in Gujarati family

MedGenome in collaboration with Kailash Cancer Hospital & Research Centre (KCHRC) in Goraj, Gujarat, discovered a genetic mutation responsible for six members of a Gujarati family suffering from Familial Adenomatous Polyposis (FAP), a rare precancerous inherited condition accounting for 1-3 per cent of cases of colorectal cancer.

MedGenome Launches Ophthatome Knowledgebase at ARVO 2018

MedGenome announced the launch of OphthatomeTM Knowledgebase, a database with more than 500,000 clinical phenotype records for ocular research at ARVO 2018, the annual meeting of the Association for Research in Vision and Ophthalmology. Ophthatome Knowledgebase was developed by MedGenome in collaboration with Narayana Nethralaya, a leading specialty eye-care hospital network based in Bangalore, India, and will be demonstrated at the conference April 29 – May 3.

12 Women on What It’s Like Being a Woman in STEM

The number of women in STEM (science, technology, engineering, and mathematics) fields is growing, but females in these industries still make up only a fraction of STEM workers when compared to men. We asked 12 women what it’s like being the minority in these fields, and this is what they had to say.

“As a woman in a professional career, I have been extremely lucky to have professors and mentors, both men and women, who have been unbiased in their attitude towards me and have encouraged and advised me through challenging situations. The biggest barrier on my end has been to strike a work-life balance; the only way I have been able to achieve this is to compromise on my own social life, outside of work.

I would encourage other women to go into STEM. It’s a wonderful and a very satisfying feeling to be able to contribute towards the progress of mankind with creative and innovative solutions.You know you will be at some point touching many other lives other than your own family. This general feeling of hope and content is very satisfying.”

– Dr. Papia Chakraborty, Senior Scientist and Head of Immuno-oncology at MedGenome

Considering genomic research?

We’re at your service